1-4 of 4
Rachel T. Barrow, BS
Close
Sort by
Journal Articles

Factor VIII Structure, Not Activity, Is the Primary Determinant of Immunogenicity in Hemophilia A and Combined Hemophilia A/Von Willebrand Disease Mice

Shannon L. Meeks, MD, Courtney Cox, M.S., John F. Healey, B.S., Ernest T Parker, B.A., Bagirath Gangadharan, MS, Rachel T. Barrow, BS, John (Pete) S. Lollar, III, M.D.
Journal: Blood
Blood (2011) 118 (21): 1187.
https://doi.org/10.1182/blood.V118.21.1187.1187
Published: 2011
Journal Articles

Non-Classical Anti-Factor VIII C2 Domain Antibodies Are Pathogenic in a Murine in Vivo Bleeding Model.

Shannon Meeks, MD, John F. Healey, BS, Ernest T. Parker, BS, Rachel T. Barrow, BS, John (Pete) Lollar, MD
Journal: Blood
Blood (2008) 112 (11): 2027.
https://doi.org/10.1182/blood.V112.11.2027.2027
Published: 2008
Journal Articles

Enhanced Anticoagulant Activity of Factor VIII Inhibitors Due to Positive Cooperativity between Two Classes of Anti-Factor VIII C2 Antibodies.

Shannon L. Meeks, MD, John F. Healey, BS, Rachel T. Barrow, BS, Ernest T. Parker, BS, Pete Lollar, MD
Journal: Blood
Blood (2007) 110 (11): 784.
https://doi.org/10.1182/blood.V110.11.784.784
Published: 2007
Journal Articles

Non-Classical Anti-Factor VIII C2 Domain Inhibitors Are Present in the Plasmas of Most Factor VIII Inhibitor Patients.

Shannon L. Meeks, MD, John F. Healey, BS, Rachel T. Barrow, BS, Ernest T. Parker, BS, Pete Lollar
Journal: Blood
Blood (2007) 110 (11): 786.
https://doi.org/10.1182/blood.V110.11.786.786
Published: 2007